Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.

Lehtoranta, Kari; Tainio, Hanna; Lukkari-Lax, Eeva; Hakonen, Tiina; Tammela, Teuvo L J

Lehtoranta, Kari; Tainio, Hanna; Lukkari-Lax, Eeva; Hakonen, Tiina; Tammela, Teuvo L J.

Affiliation

Lehtoranta K; Deaconess Institute in Helsinki, Finland. karileht@nettilinja.fi

Scand J Urol Nephrol ; 36(1): 18-24, 2002 Feb.

Article in En | MEDLINE | ID: mdl-12002352

Subject(s)

Cholinergic Antagonists/administration & dosage; Mandelic Acids/administration & dosage; Urinary Bladder, Neurogenic/drug therapy; Administration, Intravesical; Adolescent; Adult; Cholinergic Antagonists/adverse effects; Cholinergic Antagonists/pharmacokinetics; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids/adverse effects; Mandelic Acids/pharmacokinetics; Middle Aged; Urinary Bladder, Neurogenic/physiopathology; Urinary Incontinence/drug therapy; Urodynamics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder, Neurogenic / Cholinergic Antagonists / Mandelic Acids Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Scand J Urol Nephrol Year: 2002 Document type: Article Affiliation country: Finland Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links